MK
Matthew Keller HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
8
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $31 |
342%
upside
| 2 | +30% |
0
%
| 30 Sep ‘25 21 days ago |
|
|
|
Buy
Reiterated
| $43 |
286%
upside
| 2 | +31% |
0
%
| 24 Sep ‘25 27 days ago |
|
|
|
Buy
Assumed
| $6 |
341%
upside
| 1 | -15% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $18 |
116%
upside
| 1 | +1.7% |
0
%
| 26 Aug ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $14 |
557%
upside
| 1 | -2.7% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $6 |
13%
upside
| 1 | +44% |
0
%
| 14 Aug ‘25 2 months ago |
|